Form 4: HCA Healthcare Director Equity Grant Disclosure

Director Michael W. Michelson received an equity grant of 925 restricted share units as part of his annual compensation.

Summary

• Director Michael W. Michelson was granted 925 restricted share units (RSUs) on April 28, 2026.
• The grant consists of 509 RSUs for the annual director equity award and 416 RSUs in lieu of annual cash retainers.
• The total beneficial ownership for the director following this transaction is 12,576 shares.
• The RSUs vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in nature.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Director opted to receive equity in lieu of cash retainers, signaling confidence in the company's long-term value.

Negatives

• None identified.

Risks

• Vesting is contingent upon continued service as a member of the Board of Directors.

Future Outlook

The RSUs are scheduled to vest in 2027, with delivery of shares occurring upon the director's departure from the Board.

Industry Context

StockSavvy.ai notes that standard director compensation packages in the healthcare sector frequently utilize a mix of cash and equity to ensure long-term alignment with corporate governance standards.

Comparison to Industry Standards

• The use of RSUs in lieu of cash retainers is a common practice among S&P 500 companies to preserve cash flow.
• The vesting schedule aligns with typical annual meeting cycles observed in large-cap healthcare firms.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 925 RSUs at the 2027 annual shareholders' meeting or the first anniversary of the grant.

Key Dates

Keywords

HCA Healthcare, Director Compensation, Equity Grant, Form 4, Insider Ownership